Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Is refractory epilepsy preventable?

Santiago Arroyo1, Martin J Brodie, Giuliano Avanzini

  • 1Epilepsy Unit, Hospital Clinic i Provincial, Barcelona, Spain.

Epilepsia
|April 16, 2002
PubMed
Summary

Approximately one-third of epilepsy patients are refractory to antiepileptic drugs (AEDs), experiencing disabling seizures. Early identification and aggressive treatment are crucial for improving outcomes in refractory epilepsy.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Investigating short-term antiseizure medication effects on interictal epileptiform discharges in idiopathic generalized epilepsy.

Clinical neurophysiology : official journal of the International Federation of Clinical Neurophysiology·2026
Same author

The TeleEPI Feasibility Study.

Studies in health technology and informatics·2026
Same author

Objective outcome assessment in epilepsy surgery using ultralong-term subcutaneous EEG: A case report.

Epilepsia open·2025
Same author

The contribution of depression and anxiety to frailty in men and women: data from a longitudinal population-based cohort study.

BMC geriatrics·2025
Same author

A comparative study of public attitudes toward people with epilepsy in Austria, Switzerland and Germany based on web-based surveys.

Epilepsy & behavior : E&B·2025
Same author

Surgical white matter disruption leads to downstream atrophy in the non-resected human brain.

Brain : a journal of neurology·2025

Area of Science:

  • Neurology
  • Pharmacogenomics

Background:

  • Epilepsy affects many individuals, with a significant portion experiencing refractory seizures despite antiepileptic drug (AED) treatment.
  • Refractory epilepsy leads to increased morbidity, reduced quality of life, and social challenges.

Purpose of the Study:

  • To highlight the challenges in managing refractory epilepsy.
  • To emphasize the need for early identification of patients likely to develop intractable epilepsy.
  • To explore potential advancements in predicting and managing refractory epilepsy.

Main Methods:

  • Review of current understanding of refractory epilepsy.
  • Discussion of limitations in predicting intractability.
  • Exploration of emerging roles for pharmacogenomics and syndromic classification.

Related Experiment Videos

Main Results:

  • A substantial number of epilepsy patients do not achieve full seizure control with AEDs.
  • Identifying patients at risk for intractability remains a clinical challenge.
  • Pediatric epilepsy classification may offer early prognostic insights.

Conclusions:

  • Early intervention and aggressive therapy in refractory epilepsy can potentially improve patient outcomes.
  • Advances in pharmacogenomics may provide better tools for predicting treatment response.
  • Timely management is key to mitigating the long-term consequences of refractory epilepsy.